乳房切除术后可触及肿块的影像学评估效用与结局
该回顾性研究纳入2009年1月至2015年12月因可触及肿块行初次影像评估的乳房切除术后患者,共118个可触及病例,全部行超声、43例行乳腺X线摄影。超声阴性预测值为97%,阳性预测值2为27%;结论提示靶向乳腺超声因高阴性预测值可作为乳房切除术后可触及肿块的首选初始影像检查,乳腺X线摄影未额外检出癌症但有助于确认良性诊断。
要点
- 靶向乳腺超声对乳房切除术后可触及肿块的阴性预测值为97%,可作为首选初始影像检查。
- 43例同时行超声和乳腺X线摄影的病例中,超声检出3例癌症,其中2例乳腺X线可见、1例乳腺X线隐匿。
- 2例超声假阴性病例均因临床怀疑程度高而接受了取样。
核心结论
- 数据提示靶向乳腺超声因高阴性预测值,应作为乳房切除术后可触及肿块的初始影像检查首选。
- 乳腺X线摄影未额外检出癌症,但有助于确认良性诊断。
- 2例超声假阴性病例支持对影像隐匿且临床可疑的可触及肿块进行触诊引导下取样。
研究设计与样本
- 回顾性研究,纳入2009年1月至2015年12月因可触及肿块行初次影像评估的乳房切除术后患者,共101例患者、118个可触及病例,分析在病例层面进行。
- 所有118个病例行超声评估,其中43个病例行乳腺X线摄影;收集临床、影像和病理结果及手术重建类型和经皮取样数据。
- 排除标准为影像检查时已知恶性肿瘤、可触及肿块不在乳房切除部位、或无活检情况下临床或影像随访不足1年。
关键影像表现/征象
- 75个仅行超声评估的病例中检出9例癌症。
- 43个同时行超声和乳腺X线摄影的病例中,超声检出3例癌症,其中2例乳腺X线可见、1例乳腺X线隐匿。
- 共12例患者的14个可触及肿块为恶性,89例患者的104个可触及肿块为非恶性。
诊断标准与关键数值
- 靶向超声的阴性预测值为97%,阳性预测值2为27%。
临床应用与阅片要点
- 靶向乳腺超声因高阴性预测值可作为乳房切除术后可触及肿块的初始影像检查首选。
- 乳腺X线摄影未额外检出癌症,但有助于确认良性诊断。
- 对影像隐匿且临床可疑的可触及肿块,支持进行触诊引导下取样。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE. The objective of our study was to assess the utility of targeted breast ultrasound and mammography in evaluating palpable lumps in the mastectomy bed. MATERIALS AND METHODS. This retrospective study identified postmastectomy patients who presented for initial imaging evaluation of palpable lumps between January 2009 and December 2015. Clinical, imaging, and pathology results were reviewed. Surgical reconstruction type and percutaneous sampling data were collected. Patients were excluded if they had known malignancy at imaging presentation, if the palpable lump was not at the mastectomy site, or if there was less than 1 year clinical or imaging follow-up in the absence of biopsy. Each palpable site was assigned as a case, and analyses were performed at the case level. RESULTS. Among the 101 patients with a history of prophylactic or therapeutic mastectomy who presented during the study period, 118 palpable cases met the inclusion criteria. All 118 cases were evaluated with ultrasound and 43 with mammography. Among the 75 cases evaluated with ultrasound alone, nine cancers were detected. Among the 43 cases evaluated with both ultrasound and mammography, three cancers were sonographically detected, of which two were mammographically visible and one was mammographically occult. There were two false-negative ultrasound cases; both underwent sampling because of the level of clinical suspicion. In total, 14 palpable lumps in 12 patients were malignant, and 104 palpable lumps in 89 patients were nonmalignant. Targeted ultrasound yielded a negative predictive value (NPV) of 97% and a positive predictive value 2 of 27%. CONCLUSION. Our data suggest that targeted breast ultrasound, with its high NPV, should be the initial imaging test of choice for palpable lumps after mastectomy. Mammography yielded no additional cancers but was helpful in confirming benign diagnoses. The two false-negative ultrasound cases support palpation-guided sampling for imaging-occult and clinically suspicious palpable lumps.
引用
- Dashevsky BZ, Hayward JH, Woodard GA, et al. Utility and Outcomes of Imaging Evaluation for Palpable Lumps in the Postmastectomy Patient. AJR Am J Roentgenol. 2019. PMID: 31039027. doi:10.2214/AJR.18.20550
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。